ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 109 filers reported holding ANIKA THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $57,462,000 | +15.8% | 1,173,660 | +13.2% | 0.01% | +10.0% |
Q3 2016 | $49,601,000 | -2.0% | 1,036,596 | +9.9% | 0.01% | -9.1% |
Q2 2016 | $50,608,000 | +21.6% | 943,296 | +1.3% | 0.01% | +10.0% |
Q1 2016 | $41,626,000 | +14.5% | 930,806 | -2.3% | 0.01% | +25.0% |
Q4 2015 | $36,356,000 | +25.7% | 952,731 | +4.8% | 0.01% | +14.3% |
Q3 2015 | $28,933,000 | +0.0% | 908,994 | +3.8% | 0.01% | 0.0% |
Q2 2015 | $28,921,000 | -21.3% | 875,608 | -1.9% | 0.01% | -22.2% |
Q1 2015 | $36,748,000 | +8.4% | 892,596 | +7.3% | 0.01% | +12.5% |
Q4 2014 | $33,890,000 | +22.1% | 831,857 | +9.9% | 0.01% | 0.0% |
Q3 2014 | $27,747,000 | -13.4% | 756,885 | +9.4% | 0.01% | -11.1% |
Q2 2014 | $32,042,000 | +16.6% | 691,614 | +3.4% | 0.01% | +12.5% |
Q1 2014 | $27,481,000 | +9.0% | 668,627 | +1.2% | 0.01% | 0.0% |
Q4 2013 | $25,210,000 | +209.7% | 660,637 | +93.9% | 0.01% | +166.7% |
Q3 2013 | $8,141,000 | +58.0% | 340,762 | +12.4% | 0.00% | +50.0% |
Q2 2013 | $5,154,000 | – | 303,157 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Caligan Partners LP | 591,675 | $17,513,580 | 14.58% |
Trigran Investments, Inc. | 1,564,541 | $46,310,413 | 4.64% |
DIKER MANAGEMENT LLC | 22,458 | $664,757 | 0.77% |
Virtus Fund Advisers, LLC | 3,490 | $103,304 | 0.74% |
Portolan Capital Management | 207,900 | $6,153,840 | 0.61% |
Virtus Investment Advisers, Inc. | 16,086 | $476,146 | 0.32% |
Ranger Investment Management | 140,205 | $4,150,068 | 0.31% |
BOOTHBAY FUND MANAGEMENT, LLC | 367,510 | $10,878,296 | 0.25% |
Riverwater Partners LLC | 9,778 | $289,429 | 0.25% |
Legato Capital Management LLC | 7,556 | $223,658 | 0.04% |